Euro zone inflation rises to 2.6% in July, above expectations

Euro zone inflation rises to 2.6% in July, above expectations


People shopping at the downtown market, Cour Lafayette, in Toulon, on July 27, 2024.

Magali Cohen / Hans Lucas | Afp | Getty Images

Headline inflation in the euro zone unexpectedly rose to 2.6% in July, the European Union’s statistics agency said Wednesday, even as price growth in the services sector eased slightly.

In June, inflation had come in at 2.5%, easing slightly from the 2.6% of May. Economists polled by Reuters had been expecting the headline figure for July to be unchanged from June’s reading at 2.5%.

Core inflation, which excludes more volatile energy, food, alcohol and tobacco prices, hit 2.9% in July, versus a Reuters estimate of 2.8%. The figure compared with a core print of 2.9% in June.

The widely watched services inflation print came in at 4% for July, down from the 4.1% of June.

Harmonized inflation inched higher in several key euro zone countries, including in leading economies Germany and France. In both countries, inflation had been at 2.5% in June and picked up to 2.6% in July.

The inflation rates come just a day after the release of the zone’s second quarter gross domestic product, which the European Union’s statistics office said grew 0.3% in the three months to the end of June.

This was above the 0.2% growth that economists polled by Reuters had expected, and came even as the euro zone’s largest economy Germany reported a 0.1% contraction.

Investors will now weigh how the fresh data will impact the European Central Bank’s trajectory for potential future interest rate cuts. The ECB held rates steady when it met earlier this month after reducing them in June. At the time, it left open the option for another cut in September.

The ECB Governing Council said it would continue to consider the dynamics and outlook of inflation, as well as the strength of monetary policy transmission in its decision-making. It stressed that was “not pre-committing to a particular rate path.”

Julien Lafargue, chief market strategist at Barclays Private Bank, on Wednesday said that the latest inflation figures are unlikely significantly impact the outlook for interest rates.

“While the hotter-than-expected headline inflation could be seen as a setback for the ECB, we don’t think it necessarily changes the narrative. Indeed, economic growth remains subdued — including the Q2 GDP print — which should help inflation remain on a downtrend,” he said.

The ECB could therefore still cut interest rates in September, Lafargue noted.



Source

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now
World

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now

Tiina Lee, the CEO of Citi U.K., expects global growth to remain resilient this year, telling CNBC that a “recessionary environment” is “not our base case.” Markets have continued to perform in an orderly way, despite the economic and geopolitical upheaval caused by the Iran conflict, which entered its 60th day on Tuesday, Lee said. […]

Read More
‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More